Mithun Daniel
Family Medicine · Atlanta, GANPI 1508206319
Payments from drug & device makers
Across 76 payments — averaging $15.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$166
- AstraZeneca$131
- Amgen$116
- Pfizer$108
- Lilly USA, LLC$99
- Biohaven Pharmaceutical Holding Company Ltd.$99
- plus $477 from 16 others
What the payments were for
- Food & beverage$1,196100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 13 | $166 |
| AstraZeneca | 9 | $131 |
| Amgen | 7 | $116 |
| Pfizer | 5 | $108 |
| Lilly USA, LLC | 7 | $99 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $99 |
| Boehringer Ingelheim | 5 | $80 |
| Nalpropion Pharmaceuticals LLC | 4 | $66 |
| Gilead | 3 | $42 |
| AbbVie | 2 | $40 |
| Johnson & Johnson | 3 | $39 |
| Eisai Inc. | 2 | $34 |
| Currax Pharmaceuticals LLC | 2 | $31 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Dynavax Technologies Corporation | 1 | $20 |
| Amarin Pharma, Inc. | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Sanofi Pasteur Inc. | 1 | $12 |
| Aytu Biopharma, Inc. | 1 | $11 |
| Shire North American Group Inc | 1 | $11 |
How this compares
$1,196 in reported general payments places this provider in the 60th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JanuviaSitagliptin Phosphate | 14 | $9,810 |
| Rosuvastatin Calcium | 20 | $485 |
| Levothyroxine Sodium | 11 | $357 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $304 |
| Amlodipine Besylate | 40 | $247 |
| Olmesartan Medoxomil | 11 | $220 |
| Atorvastatin Calcium | 29 | $185 |
| Gabapentin | 11 | $170 |
| Lisinopril | 15 | $106 |
| Metformin Hcl | 23 | $90 |
| Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid | 12 | $71 |
| Losartan Potassium | 12 | $66 |
| Escitalopram Oxalate | 13 | $43 |
| Pantoprazole Sodium | 12 | $19 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckJanuvia | $12 | $9,81014 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Atlanta
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Nadia CameronAtlanta$2.1M
- Otis PowellAtlanta$608K
- Thinh NguyenAtlanta$427K
- Patricia MarshAtlanta$175K
- Contessa MetcalfeAtlanta$157K
- Michelle EvansAtlanta$127K
- Mark TannerAtlanta$94K
- Ambar KulshreshthaAtlanta$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.